Abbrea Capital, LLC Gilead Sciences, Inc. Transaction History

Abbrea Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $188,636 - $214,915	2,440 New	2,440 $202,000
Q2 2020 Aug 11, 2020	SELL	$72.34 - $84.0 $207,615 - $241,080	-2,870 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$62.63 - $80.22 $179,748 - $230,231	2,870 New	2,870 $215,000
Q2 2018 Aug 08, 2018	SELL	$64.88 - $75.68 $181,015 - $211,147	-2,790 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$72.84 - $88.8 $203,223 - $247,752	2,790 New	2,790 $210,000
Q4 2017 Feb 01, 2018	SELL	$71.15 - $83.52 $189,187 - $222,079	-2,659 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$72.11 - $85.47 $191,740 - $227,264	2,659	2,659 $215,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Abbrea Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Abbrea Capital, LLC with notifications on news.